• Sign In
  • Sign Up
  • Sign In
  • Sign Up
  • Home
  • Cardiology
  • Endocrinology
  • Neurology
  • Nephrology
  • Dermatology
  • Oncology
  • Obstetrics & Gynecology
  • Otolaryngology
  • Home
  • Cardiology
  • Endocrinology
  • Neurology
  • Nephrology
  • Dermatology
  • Oncology
  • Obstetrics & Gynecology
  • Otolaryngology
ADA 86th Scientific Sessions ’26

Complementary Brain Action of Amylin and GLP-1 Receptor Agonism, Spatiocellular Mapping

A spatiocellular mapping study of amylin and GLP-1 receptor expression in the human brain provides mechanistic evidence supporting complementary, not redundant, central action of these

Read More »
July 9, 2026
ADA 86th Scientific Sessions ’26

Early Plasma Metabolomic Adaptation Predicts Long-Term Weight Loss Success

A study characterises early plasma metabolomic adaptation during dietary interventions for longterm weight loss success and improved cardiometabolic health, identifying metabolomic biomarkers that distinguish dietary

Read More »
July 8, 2026
ADA 86th Scientific Sessions ’26

Tissue-Specific Mitochondrial Adaptations Parallel Bariatric Metabolic Improvements

A study characterises tissue-specific mitochondrial adaptations that parallel metabolic improvements following bariatric surgery, providing mechanistic insight into the multitissue biological transformation underlying surgery’s substantial metabolic

Read More »
July 6, 2026
ADA 86th Scientific Sessions ’26

Genetic and Functional Evidence Linking CYP26B1 Variant 3 to BMI

A study presents genetic and functional evidence linking CYP26B1 transcript variant 3 to body mass index, identifying a cytochrome P450 family member with potential roles

Read More »
July 2, 2026
ADA 86th Scientific Sessions ’26

Digital Engagement Features Tied to Blood-Glucose Improvement in Real-World Diabetes

A DarioHealth-affiliated team reports that in a real-world digital diabetes cohort, consistent longitudinal engagement, rather than singleinteraction touchpoints, was strongly linked to glycaemic improvement, supporting

Read More »
July 1, 2026
ADA 86th Scientific Sessions ’26

CHW-Coached ‘Food Is Medicine’ Program Improves Diabetes Outcomes

A UC Davis-affiliated team reports that enhancing a ‘Food Is Medicine’ programme with coaching from community health workers (CHWs) delivers significant improvements in health outcomes

Read More »
June 30, 2026
ADA 86th Scientific Sessions ’26

Time to Minimal Residual C-Peptide, A New T1D Trial Efficacy Measure

A team from Boston and Tampa proposes ‘Time to Minimum Residual C-Peptide’ (TMRCP), a longitudinal endpoint that captures the trajectory of β-cell secretory loss, as

Read More »
June 29, 2026
ADA 86th Scientific Sessions ’26

Early Weight-Loss Velocity Guides Precision Escalation in Obesity Treatment

A University of Milan group reports that early weight-loss velocity following obesity treatment initiation predicts long-term response, providing a practical, clinic-anchored decision rule for when

Read More »
June 22, 2026
ADA 85th Scientific Sessions ’25

Modelling the Legacy Effect of Glycaemic Exposure on Long-Term Cardiovascular Disease in Newly Diagnosed Type 2 Diabetes

This study was presented as part of the session “Diabetes and Heart Talk” on June 23rd, 2025, during the 85th ADA Scientific Sessions held in

Read More »
August 26, 2025
ADA 85th Scientific Sessions ’25

Can We Improve the Quality of Weight Loss by Augmenting Fat Mass Loss while Preserving Lean Mass? The BELIEVE Study of Bimagrumab + Semaglutide

This study was presented on June 23rd, 2025, during the 85th ADA Scientific Sessions held in Chicago, IL. A groundbreaking obesity treatment combining two medications

Read More »
August 25, 2025
Page1 Page2 Page3 Page4 Page5
Latest Conferences
  • Insulin Clearance Tracks Rapid Disease Progression in Preclinical T1D
  • Glucose, Not Insulin, Appears to Be the Main Regulator of Glucagon Secretion in Healthy Individuals
  • Semaglutide and Obstructive Sleep Apnea, SELECT Post-Hoc Analysis
  • Metformin Randomization Associated with Prevalent Cognitive Impairment in DPP Outcomes Study
  • Semaglutide Reduces COVID-19 Complications and All-Cause Death, SELECT + FLOW + SOUL Pooled
Societies
  • ACC: American College of Cardiology
  • ADA: American Diabetes Association
  • ASN: American Society of Nephrology
  • BAD: British Association of Dermatologists
  • ERA EDTA: European Renal Association – European Dialysis and Transplant Association
  • ESC: European Society of Cardiology
  • ISN: International Society of Nephrology
  • WCPD: World Congress of Pediatric Dermatology
  • AHA: American Heart Association
  • AAD: American Association of Dermatology
  • AACE: American Association of Clinical Endocrinology
  • ADA: American Diabetes Association
  • ASN: American Society of Nephrology
  • ISN: International Society of Nephrology
  • IASP: International Association for the Study of Pain
  • SCAI: Society for Cardiovascular Angiography and Interventions
  • AAO-HNS: American Academy of Otolaryngology–Head and Neck Surgery
Speciality
  • Cardiology
  • Endocrinology
  • Nephrology
  • Neurology
  • Dermatology
  • Obstetrics & Gynecology
  • Pain
  • Respiratory
  • Otolaryngology
Tags
AACE ACC ADA AHA ASN BAD ERA ESC ISN ISN-WCN 2021 Kidney Week 2020 SCAI WCPD wcpn

© All rights reserved.